Study quantifies diabetes management outcomes.

PubMed · 10623000

Study quantifies diabetes management outcomes.

Abstract

Diabetes mellitus currently affects some 16 million Americans, and more than 150,000 people die from diabetes and its complications each year. Studies show that many, if not all, of the complications of diabetes can be slowed or even prevented by better management on the part of the health care team and the patient. A 17-month study by Roche Diagnostics and Sierra Health Services examined the impact of expediting the availability of patient and treatment-option information on patient outcomes.

Explore related subjects

Diabetes Mellitus Disease Management Humans Information Management Outcome Assessment, Health Care Patient Education as Topic Primary Health Care Quality Assurance, Health Care Risk Assessment Severity of Illness Index United States Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

1999. Study quantifies diabetes management outcomes.. https://pubmed.ncbi.nlm.nih.gov/10623000/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

JAMA patient page. Insulin.

Explore the source record for details and available documents.

Diabetes Mellitus↗

PubMed2007

Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues.

The purification of animal insulin preparations and the use of human recombinant insulin have markedly reduced the incidence but not completely suppressed the occurrence of insulin allergy manifestations. Advances in technologies concerning the mode of delivery of insulin, i.e. continuous subcutaneous insulin infusion (CSII), and the use of insulin analogues, resulting from the alteration in the amino acid sequence of the native insulin molecule, may influence the immunogenicity and antigenicity of native insulin. Instead of increasing allergy reactions, CSII has been reported to represent a successful alternative treatment in diabetic patients presenting local or generalized allergy to insulin or other components (zinc, protamine) of conventional treatment. Most recent reports concern CSII-treated patients using short-acting insulin analogues (essentially insulin lispro), although the precise role of these insulin analogues remains unclear as allergy to them has also been described. Finally, data on antigenicity and immunogenicity of long-acting insulin analogues (glargine, detemir), which may mimic the basal insulin delivery with CSII, remain scarce at present.

Diabetes Mellitus↗

PubMed2007

Effects of glucose homeostasis on protein metabolism in patients with advanced chronic kidney disease.

Insulin deficiency is known to be associated with a state of increased muscle protein breakdown; this process is mediated by the ubiquitin-proteasome pathway. Convincing in vitro data are further supported by extensive studies in humans with insulin deprivation and are further substantiated by reversal of muscle protein breakdown with insulin treatment. In patients with end-stage renal disease (ESRD) and diabetes mellitus (DM), muscle protein breakdown is enhanced in both acute and chronic conditions. Recent data also point to the potential protein catabolic effects of insulin resistance combined with insulin deficiency. Because ESRD is associated with a state of insulin resistance, uremic muscle wasting may also be mediated by this pathway.

Diabetes Mellitus↗